A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01464034 · TERMINATED
Trial details
- NCT number
- NCT01464034
- Sponsor
- Criterium, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2020-07-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.